SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001387131-19-004459
Filing Date
2019-06-14
Accepted
2019-06-14 16:34:41
Documents
9
Effectiveness Date
2019-06-14

Document Format Files

Seq Description Document Type Size
1 INITIAL REGISTRATION STATEMENT tnxp-s8_061419.htm S-8 121858
2 CERTIFICATE OF AMENDMENT ex3-07.htm EX-3.07 2603
3 OPINION OF BROWNSTEIN HYATT FARBER SCHRECK, LLP ex5-01.htm EX-5.01 10124
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23-01.htm EX-23.1 3621
5 GRAPHIC ex3-07_img001.jpg GRAPHIC 117236
6 GRAPHIC ex3-07_img002.jpg GRAPHIC 536939
7 GRAPHIC ex3-07_img003.jpg GRAPHIC 220114
8 GRAPHIC ex5-1_img001.jpg GRAPHIC 12563
9 GRAPHIC ex5-1_img002.jpg GRAPHIC 19320
  Complete submission text file 0001387131-19-004459.txt   1387890
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-232137 | Film No.: 19899360
SIC: 2834 Pharmaceutical Preparations